529 PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) PROMOTES CHONDROGENIC DIFFERENTIATION OF BONE MARROW MESENCHYMAL STEM CELLS (BM-MSCS) GROWN ON TYPE I COLLAGEN SUPPORTS  by Diaz-Prado, S. et al.
Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256 S237
alter the normal gelation time of the HyA hydrogels. In contrast to the stiff
agarose hydrogel, HyA hydrogels were relatively soft and slightly sticky.
In all hydrogel constructs, cells appeared spherical and more than 70% of
cells remained viable at 24 hrs after encapsulation, regardless of seeding
density (Fig. 1). Long term cell viability and proliferation were analyzed in
HyA-2 constructs at two cell densities. The viability of encapsulated cells
remained above 80-90% at low density, while it decreased to 60% at high
density over the 14 days culture duration (Fig. 2). No cell proliferation
was observed in the cell/HyA-2 constructs (Fig. 3). The number of hMSCs
present in the HyA-2 hydrogel remained unchanged with culture duration
at the lower seeding density, but decreased signiﬁcantly at higher density
(Fig. 3).
Figure 1. Viability of encapsulated hMCSs in four different hydrogels at two seeding den-
sities.
Figure 2. Viability of encapsulated hMCSs in HyA-2 at two seeding densities.
Figure 3. Proliferation of encapsulated hMSCs in HyA-2 during 14 days culture.
Conclusions: In this study, we evaluated the cellular response of hM-
SCs to three novel hyaluronan hydrogel formulations. Our initial results
demonstrated that the HyA hydrogels have the capacity to encapsulate
adult human stem cells without altering the intrinsic gelation time. All
hydrogels supported cell survival over an extended culturing period. Stem
cells regained their 3-D phenotype and appeared to switch from the
proliferating to differentiation state. The in situ, crosslinking capacity of
these HyA hydrogels may allow for the preparation of cell/gel mixture ex
vivo for subsequent delivery to a desired location where the crosslinking
process can be completed. Future studies will include evaluation of cell
differentiation in the hydrogel, secretion of cytokines from encapsulated
cells, and cell release from the hydrogel construct. Results from these
studies will shed light on the suitability of these HyA hydrogels as a cell
delivery carrier into targeted disease sites or tissue repair applications.
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Purpose: Mesenchymal Stem cells (MSCs) are useful multipotent stem
cells that are found in many tissues. Due to important ethic and safety
limitations for clinical use of pluripotent embryonic stem cells, MSCs are
predominantly used in human clinical assays. While MSCs can usually be
isolated from adults via bone marrow aspiration (BM-MSCs), MSCs derived
from the discarded umbilical cord, more precisely from Wharton’s jelly,
offer a low-cost and pain-free collection method of MSCs that may be cryo-
genically stored. Moreover, the feature of Wharton’s jelly MSCs (WJ-MSCs)
is intermediate between embryonic and adult MSCs. Brieﬂy, compared to
adult stem cells, they show an increased telomerase activity and compared
to embryonic stem cells, they have a lower rate of DNA lesions after cell
division. These properties are extremely favorable for considering them
for tissue engineering purpose. However, culture expansion of MSCs is a
prerequisite, since high absolute numbers of stem cells are required to
reach a clinical dose. Thus, the aim of this study was to characterize these
WJ-MSCs during monolayer expansion (from P0 to P10), under normoxia
or hypoxia conditions.
Methods: With the consent of the parents, fresh human umbilical cords
were obtained from full-term births, aseptically stored in sterile saline and
processed within 6 hours from partum to obtain the WJ-MSCs. Individual
UC components were dissected, diced into 1-2 mm3 fragments, and aligned
in explant cultures from which migrating cells were isolated by scraping
until reaching P10 in both normoxia and hypoxia cultures. Stem cells were
expanded using α-MEM 10% fetal calf serum (FCS) based media. For each
culture conditions, characterization was performed, at each passage, at two
levels: cellular level (cell morphology, immunophenotyping) and functional
level (differentiation potential and metabolic activity).
Results: We found that normoxia or hypoxia conditions inﬂuenced
metabolic activity of MSCs and population doubling time. Moreover,
whatever culture conditions, we observed, at early passages, modiﬁcations
of cell morphology suggesting the possible presence of cellular subpopu-
lations. Using ﬂow cytometric analysis, our data revealed that WJ-MSCs
express matrix receptors (CD44, CD166, CD90, CD271) and integrin markers
(CD29) but not hematopoietic lineage markers (CD34, CD45, HLA-class II).
Interestingly, these cells also express signiﬁcant amounts of mesenchy-
mal stem cell markers (SH2, SH3). Finally, individual WJ-MSCs could be
selectively differentiated into osteoblasts, chondrocytes, and adipocytes.
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Purpose: Most efforts performed to repair injuries of the articular cartilage
focus on the limitations of this tissue to heal injuries and how to promote
vascularization. A current challenge is to avoid generation of a ﬁbro
cartilaginous tissue that does not mimic hyaline articular cartilage. The
transplantation of mesenchymal stem cells (MSCs) has been suggested as
an alternative therapeutic approach for treatment of cartilage defects.The
aim of this study was to evaluate the effects of both N- and C-terminal
fragments of PTHrP to promote chondrogenesis using BM-MSCs cultured
on pure equine type I collagen supports.
Methods: MSCs were isolated from human BM stroma and were expanded
in monolayer cultures. BM-MSCs were characterized by ﬂow cytometry
using hematopoietic and MSC markers. At the 3-4th passage, BM-MSCs
were cultured on 1×1cm2 collagen supports, pre-treated or not with PTHrP
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(1-36) or PTHrP (107-139) (100 nM) for 1.5 h. The cell density over the
support was 50,000 cells/cm2. We performed 18 groups: 9 in normoxia
(humidiﬁed atmosphere with 5% CO2) and the other 9 in hypoxia condi-
tions (obtained with GasPak™ EZ Anaerobe Pouch System, BD Diagnostics)
(see table 1). Within each group, 5 replicas were done. The study period
was 14 days for the groups tested in hypoxia and 21 days for those in
normoxia. BM-MSCs were cultured in chondrogenic differentiation medium
(Lonza, Group Ltd, Switzerland) or DMEM with 20% FBS. Control groups
(VII, VIII and IX) were mature human chondrocytes grown in DMEM with
10% FBS. Chondrogenic differentiation was conﬁrmed by histochemical and
immunohistochemical analysis, and transmission and scanning electronic
microscopy.
Results: BM-MSCs and chondrocytes were able to grow on equine type
I collagen supports, with or without the presence of PTHrP fragments,
producing extracellular matrix. Both cell types showed their typical
morphology; their phenotypes were conﬁrmed by SOX2 and OCT3/4 im-
munoﬂuorescence analysis, in the case of BM-MSCs, and by Masson’s
trichrome stainings for proteoglycans and immunostainings to detect the
presence of type II collagen, in the case of chondrocytes. BM-MSCs (groups
I to III) grown on the collagen substrate were able to differentiate into
chondrocyte-like cells which were positive for Masson’s trichrome and
type II collagen. However, chondrogenesis was more evident in cultures
treated with the PTHrP fragments. Electronic microscopy revealed that the
latter cultures showed a large amount of lipid or glycoprotein vacuoles,
many ribosomes and a large endoplasmic reticulum, characteristic of the
cells with a high activity. These differentiating BM-MSCs also showed many
extensions that might secrete adhesion molecules to adhere to the collagen
support.
Table 1. Groups of study in normoxia and hypoxia conditions
Group Cells PTHrP treatment Culture medium
Group I BM-MSCs C-terminal fragment Chondrogenic
Group II BM-MSCs N-terminal fragment Chondrogenic
Group III BM-MSCs No treatment Chondrogenic
Group IV BM-MSCs C-terminal fragment DMEM + 20% FBS
Group V BM-MSCs N-terminal fragment DMEM + 20% FBS
Group VI BM-MSCs No treatment DMEM + 20% FBS
Group VII Chondrocytes C-terminal fragment DMEM + 10% FBS
Group VIII Chondrocytes N-terminal fragment DMEM + 10% FBS
Group IX Chondrocytes No treatment DMEM + 10% FBS
Figure 1. Immunohistochemistry analysis of BM-MSCs (group II) grown on pure equine
type I collagen supports in normoxia conditions.
Conclusions: Our data demonstrate that pure equine type I collagen sup-
ports are optimal for BM-MSCs and chondrocyte growth. Moreover, both
N- and C-terminal fragments of PTHrP improve the capacity of BM-MSCs to
differentiate into chondrocyte-like cells.
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Purpose: Mesenchymal stem cells (MSCs) are an accepted candidate for
cell-based therapy of rheumatic diseases. Recently, like aggregation and
TGF-beta delivery, hypoxia has been indicated as crucial for complete
chondrogenesis. The aim of this study was to analyze bone marrow MSCs
(BM-MSCs) differentiation capacity under normoxic and hypoxic culture
conditions.
Methods: MSCs, isolated from bone marrow stroma (n= 3) and expanded
in monolayer cultures, were characterized by ﬂow cytometry and differen-
tiated towards adipocytes, osteoblasts and chondrocytes under normoxic
or hypoxic conditions using commercial differentiation medium. The dif-
ferentiations were conﬁrmed by histochemical, immunohistochemical and
qPCR analysis comparing each treated point with a control point made of
cells grown in DMEM and FBS.
Results: BM-MSCs from the three donors displayed only few phenotypical
differences in surface antigens expressions. Analyzing marker genes ex-
pression levels of the treated cells (T.C.) compared to its control point (CTL)
for each lineage showed a good differentiation in normoxic conditions and
the absence of this differentiation capacity in hypoxic cultures (as shown
in the table). Histochemical analysis conﬁrmed these results.
For each gene, the reference value 1 is given to its expression level in the control point
Lineage Gene Normoxic Condition Hypoxic Condition
CTL T.C. CTL T.C.
Adipogenic LPL 1,00 972,13 1,00 1,92
FABP4 1,00 48934,74 1,00 0,14
AMP1 1,00 1247,03 1,00 3,64
Osteogenic ALP 1,00 19,14 1,00 1,73
OP 1,00 12,13 1,00 1,13
Chondrogenic SOX9 1,00 6,87 1,00 0,65
AGG 1,00 25,58 1,00 3,31
COL1A1 1,00 17,47 1,00 5,36
COL2A1 / 1,00 (Cp=31) / /
Conclusions: In our experimental conditions, hypoxia affects the differ-
entiation potential of BM-MSCs. Adipogenic, osteogenic and chondrogenic
differentiations are absent. Our results may provide information of the
differential molecular mechanisms regulating the MSCs differentiations.
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Purpose: Collagen gels could be used as carriers in cell therapy to improve
cell retention and distribution in the defect. Hydroxyapatite could be added
to gels to improve mechanical properties and reduce gel contraction. The
aim of this work was to analyze the feasibility to incorporate hydroxyap-
atite into collagen gels and culture mesenchymal stem cells inside it.
Methods: Human bone marrow mesenchymal stem cells (MSC) were used
in this study. They were characterized by phenotypic marker analysis
(CD34-, CD45-, HLA-DR-, CD73+, CD90+, CD105+, CD166+) and ostegenic,
chondrogenic and adipogenic differentiation potential. Gels were prepared
by mixing rat tail type I collagen (ColI), hydroxyapatite microparticles
(Hap, 30-80 μm) and MSCs to obtain a ﬁnal concentration of 3mg/ml ColI,
2mg/ml Hap and 5 105 cell/ml. pH was adjusted to 7.0 with NaOH and
350ml of the mixture was distributed on each well of 48-well culture
